Clinical and Translational Discovery (Oct 2024)

Otubain 2 promotes muramyl dipeptide‐mediated anti‐colitogenic effects due to de‐ubiquitination of receptor interaction protein 2

Jochen Mattner

Affiliations

Jochen Mattner: Mikrobiologisches Institut‐Klinische Mikrobiologie, Immunologie und Hygiene Universitätsklinikum Erlangen and Friedrich‐Alexander‐Universität (FAU) Erlangen‐Nürnberg Erlangen Germany

DOI: https://doi.org/10.1002/ctd2.70014
Journal volume & issue: Vol. 4, no. 5
pp. n/a – n/a

Abstract

No abstracts available.

Published in Clinical and Translational Discovery

ISSN: 2768-0622 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://onlinelibrary.wiley.com/journal/27680622

About the journal